Daniel Grosslight
Stock Analyst at Citigroup
(1.11)
# 3,750
Out of 4,981 analysts
102
Total ratings
32.79%
Success rate
-13.42%
Average return
Main Sectors:
Stocks Rated by Daniel Grosslight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OMI Owens & Minor | Maintains: Buy | $11 → $7 | $5.34 | +31.09% | 7 | Aug 12, 2025 | |
| HCAT Health Catalyst | Downgrades: Neutral | $6.5 → $3.5 | $3.13 | +11.82% | 10 | Aug 8, 2025 | |
| AGL agilon health | Downgrades: Neutral | $3 → $1 | $1.07 | -6.54% | 6 | Aug 6, 2025 | |
| WAY Waystar Holding | Initiates: Buy | $45 | $37.36 | +20.45% | 1 | Jun 25, 2025 | |
| CAH Cardinal Health | Maintains: Neutral | $157 → $170 | $152.24 | +11.67% | 9 | Jun 13, 2025 | |
| HIMS Hims & Hers Health | Maintains: Sell | $25 → $30 | $55.50 | -45.95% | 11 | May 6, 2025 | |
| TDOC Teladoc Health | Maintains: Neutral | $11 → $8.75 | $7.68 | +13.93% | 11 | Apr 25, 2025 | |
| EVH Evolent Health | Maintains: Buy | $21 → $18 | $9.02 | +99.56% | 4 | Jan 10, 2025 | |
| GDRX GoodRx Holdings | Maintains: Buy | $7 → $6.25 | $4.19 | +49.16% | 7 | Jan 10, 2025 | |
| MCK McKesson | Maintains: Buy | $713 → $677 | $711.42 | -4.84% | 7 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $35 | $24.19 | +44.69% | 6 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $22.79 | +9.70% | 1 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $10 | $4.00 | +150.00% | 7 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $7 → $8 | $12.95 | -38.22% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1.25 | $2.09 | -40.19% | 5 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7 → $3.5 | $2.56 | +36.72% | 2 | Nov 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $9.29 | +39.94% | 1 | Dec 11, 2019 |
Owens & Minor
Aug 12, 2025
Maintains: Buy
Price Target: $11 → $7
Current: $5.34
Upside: +31.09%
Health Catalyst
Aug 8, 2025
Downgrades: Neutral
Price Target: $6.5 → $3.5
Current: $3.13
Upside: +11.82%
agilon health
Aug 6, 2025
Downgrades: Neutral
Price Target: $3 → $1
Current: $1.07
Upside: -6.54%
Waystar Holding
Jun 25, 2025
Initiates: Buy
Price Target: $45
Current: $37.36
Upside: +20.45%
Cardinal Health
Jun 13, 2025
Maintains: Neutral
Price Target: $157 → $170
Current: $152.24
Upside: +11.67%
Hims & Hers Health
May 6, 2025
Maintains: Sell
Price Target: $25 → $30
Current: $55.50
Upside: -45.95%
Teladoc Health
Apr 25, 2025
Maintains: Neutral
Price Target: $11 → $8.75
Current: $7.68
Upside: +13.93%
Evolent Health
Jan 10, 2025
Maintains: Buy
Price Target: $21 → $18
Current: $9.02
Upside: +99.56%
GoodRx Holdings
Jan 10, 2025
Maintains: Buy
Price Target: $7 → $6.25
Current: $4.19
Upside: +49.16%
McKesson
Jan 10, 2025
Maintains: Buy
Price Target: $713 → $677
Current: $711.42
Upside: -4.84%
Jan 10, 2025
Maintains: Buy
Price Target: $31 → $35
Current: $24.19
Upside: +44.69%
Apr 22, 2024
Initiates: Buy
Price Target: $25
Current: $22.79
Upside: +9.70%
Aug 9, 2023
Maintains: Neutral
Price Target: $9 → $10
Current: $4.00
Upside: +150.00%
Aug 4, 2023
Downgrades: Sell
Price Target: $7 → $8
Current: $12.95
Upside: -38.22%
Apr 28, 2023
Maintains: Neutral
Price Target: $1.5 → $1.25
Current: $2.09
Upside: -40.19%
Nov 16, 2021
Downgrades: Neutral
Price Target: $7 → $3.5
Current: $2.56
Upside: +36.72%
Dec 11, 2019
Initiates: Outperform
Price Target: $13
Current: $9.29
Upside: +39.94%